Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score
Adult
Male
MESH: Registries
Adolescent
610
MESH: Multivariate Analysis
MESH: Prognosis
MESH: Kidney Transplantation
Young Adult
03 medical and health sciences
MESH: Lymphoproliferative Disorders
Postoperative Complications
0302 clinical medicine
MESH: Risk Factors
Risk Factors
MESH: Postoperative Complications
616
Humans
Prospective Studies
Registries
Aged
MESH: Adolescent
MESH: Aged
MESH: Middle Aged
MESH: Humans
MESH: Adult
MESH: Follow-Up Studies
[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences
Middle Aged
Prognosis
Kidney Transplantation
Survival Analysis
MESH: Prospective Studies
MESH: Male
Lymphoproliferative Disorders
3. Good health
MESH: France
[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences
MESH: Young Adult
MESH: Survival Analysis
Multivariate Analysis
Female
France
MESH: Female
Follow-Up Studies
DOI:
10.1200/jco.2012.43.2344
Publication Date:
2013-02-20T02:32:25Z
AUTHORS (39)
ABSTRACT
Purpose Post-transplantation lymphoproliferative disorder (PTLD) is associated with significant mortality in kidney transplant recipients. We conducted a prospective survey of the occurrence of PTLD in a French nationwide population of adult kidney recipients over 10 years. Patients and Methods A French registry was established to cover a nationwide population of transplant recipients and prospectively enroll all adult kidney recipients who developed PTLD between January 1, 1998, and December 31, 2007. Five hundred patient cases of PTLD were referred to the French registry. The prognostic factors for PTLD were investigated using Kaplan-Meier and Cox analyses. Results Patients with PTLD had a 5-year survival rate of 53% and 10-year survival rate of 45%. Multivariable analyses revealed that age > 55 years, serum creatinine level > 133 μmol/L, elevated lactate dehydrogenase levels, disseminated lymphoma, brain localization, invasion of serous membranes, monomorphic PTLD, and T-cell PTLD were independent prognostic indicators of poor survival. Considering five variables at diagnosis (age, serum creatinine, lactate dehydrogenase, PTLD localization, and histology), we constructed a prognostic score that classified patients with PTLD as being at low, moderate, high, or very high risk for death. The 10-year survival rate was 85% for low-, 80% for moderate-, 56% for high-, and 0% for very high–risk recipients. Conclusion This nationwide study highlights the prognostic factors for PTLD and enables the development of a new prognostic score. After validation in an independent cohort, the use of this score should allow treatment strategies to be better tailored to individual patients in the future.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (124)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....